Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic‐reperfusion injury

Acute kidney disease (AKI) leads to increased risk of progression to chronic kidney disease (CKD). Antithrombin III (ATIII) is a potent anticoagulant with anti‐inflammatory properties, and we previously reported that insufficiencies of ATIII exacerbated renal ischaemia‐reperfusion injury (IRI) in ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Jianyong, Wang, Feng, Kong, Yiwei, Wu, Rui, Zhang, Guangyuan, Wang, Niansong, Wang, Ling, Lu, Zeyuan, Liang, Mingyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706518/
https://www.ncbi.nlm.nih.gov/pubmed/28767184
http://dx.doi.org/10.1111/jcmm.13261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706518/
https://www.ncbi.nlm.nih.gov/pubmed/28767184
http://dx.doi.org/10.1111/jcmm.13261

Ejemplares similares